Nachrichten zur Akebia Therapeutics Aktie

Akebia Therapeutics (AKBA) Presents At 2019 Jefferies Global Healthcare Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q1 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia Therapeutics, Inc. (AKBA) Q1 2019 Earnings Call Transcript

AKBA earnings call for the period ending March 31, 2019....…

Pharma - Vifor und Akebia weiten Lizenzabkommen aus

Vifor Pharma und das US-Biopharmaunternehmen Akebia Therapeutics haben ein bestehendes Lizenzabkommen ausgeweitet. Damit erreicht Vifor bis zu 60 Prozent der…

Akebia Therapeutics: Still A Buy Post-Merger

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia Therapeutics (AKBA) Q4 2018 Earnings Conference Call Transcript

AKBA earnings call for the period ending December 31, 2018....…

Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q4 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Akebia Therapeutics, Momo, and Switch Jumped Today

Good news on several fronts helped lift many stocks....…

Why Akebia Therapeutics Is Soaring Today

Great news from two late-stage studies lit a fire under the biopharmaceutical stock....…

Akebia surges after positive results in Phase 3 studies of kidney disease-related anemia

Akebia Therapeutics Inc (NASDAQ:AKBA) surged Tuesday after reporting positive results from a pair of Phase 3 studies on the treatment…

Thinking about buying stock in Aurora Cannabis Inc., Akebia Therapeutics, Bio-Path Holdings, Globus Maritime Ltd., or Stitch Fix Inc.-

NEW YORK , March 12, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for…

The Daily Biotech Pulse: Zafgen Wont File IND For Metabolic Disorder Drug, Positive Results For Akebias Anemia Drug

Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week…

Analysts Estimate Akebia Therapeutics (AKBA) to Report a Decline in Earnings: What to Look Out for

Akebia Therapeutics (AKBA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

Akebia Therapeutics (AKBA) Upgraded to Buy: Heres What You Should Know

Akebia Therapeutics (AKBA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects.…

Akebia: Is This A Potential Winner-

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Keryxs Long-Awaited Merger With Akebia Complete

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Seth Klarman Gains Stake In Akebia Therapeutics

Klarmans Kleryx holding transitions into stake in fully integrated kidney care company with investors approval...…

Akebia Poised To Become Renal Powerhouse With Keryx Merger, Raymond James Says

Akebia Therapeutics Inc (NASDAQ: AKBA) announced shareholder approval this week for its merger with Keryx Biopharmaceuticals (NASDAQ: KERX). Latest…

Why Akebia Therapeutics Is Soaring Today

Traders cheer after the company completes its merger agreement. Heres what investors need to know....…

Akebia Therapeutics Is An Attractive Investment In 2018

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia Therapeutics (AKBA) Reports Q3 Loss, Tops Revenue Estimates

Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of 40.26% and 33.88%, respectively, for the quarter ended September 2018. Do…

Akebia Therapeutics (AKBA) Presents At Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia Therapeutics Inc (AKBA) CEO John Butler on Q2 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia Therapeutics (AKBA) Reports Q2 Loss, Tops Revenue Estimates

Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -15.38% and 0.09%, respectively, for the quarter ended June 2018. Do…

Keryx Biopharmaceuticals And Akebia Therapeutics: Was The Reaction To The Merger Announcement Justified-

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia Therapeutics, Inc. (AKBA) Merger & Acquisition Call - Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Heres Why Keryx Biopharmaceuticals and Akebia Therapeutics Are Plunging Today

Shares of both companies tumble after the two entities announced the signing of a merger agreement. Heres what investors need…

Akebia and Keryx Combine to Fight Chronic Kidney Disease

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia Keryx Merger Investor Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia Therapeutics and Keryx Biopharmaceuticals to merge in all-stock deal

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

CORRECTED-Ex-Akebia employee jailed for night as insider trading trial starts

BOSTON, June 26 (Reuters) - A former Akebia Therapeutics Inc employee accused of engaging in an insider trading scheme must spend a…

Ex-Akebia employee jailed for night as insider trading trial starts

BOSTON (Reuters) - A former Akebia Therapeutics Inc employee accused of engaging in an insider trading scheme must spend…

Technical Perspectives on Biotech Stocks -- Adaptimmune Therapeutics, Akebia Therapeutics, Alder Biopharma, and Alexion Pharma

NEW YORK, April 19, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. …

Akebia (AKBA) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-Akebia Therapeutics Announces Pricing Of Public Offering Of Common Stock

* AKEBIA THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK...…

Akebia Therapeutics (AKBA) CEO John Butler on Q4 2017 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-Akebia Therapeutics Inc Files For Potential Mixed Shelf Offering Amount Not Disclosed - SEC Filing

* AKEBIA THERAPEUTICS INC FILES FOR POTENTIAL MIXED SHELF OFFERING; AMOUNT NOT DISCLOSED - SEC FILING Source text (http://bit.ly/2tG5aJJ) Further company coverage: (Reuters.Brief@thomsonreuters.com)...…

Your Daily Pharma Scoop: Akebia Update, Rexahn Data, Concert Commences Enrollment

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia (AKBA) Presents At BIO CEO & Investor Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-Akebia Therapeutics Gives Update On Vadadustat Development Program

* AKEBIA THERAPEUTICS PROVIDES UPDATE ON VADADUSTAT DEVELOPMENT PROGRAM...…

Your Daily Pharma Scoop: ChemoCentryx Surges, Akebia Gets Positive News, Atara Prices Public Offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics, Akebia Therapeutics, Calithera Biosciences and GlycoMimetics

The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics, Akebia Therapeutics, Calithera Biosciences and GlycoMimetics...…

Akebia Therapeutics Is A Buy With The Recent Stock Price Pullback

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biotech Stock Performance Review -- Agenus, Akebia Therapeutics, Acorda Therapeutics, and Advaxis

NEW YORK, October 20, 2017 /PRNewswire/ -- If you want a Stock Review on AGEN, AKBA, ACOR,…

AKBA Hits New 52-week High, PMD Launches Hair Test, Mateon Runs Out Of FOCUS

Todays Daily Dose brings you news about Akebias phase II trial of kidney disease drug; Ascendis progress in hypoparathyroidism trial;…

BRIEF-Akebia announces positive top-line results from phase 2 study of vadadustat in Japanese patients

* Akebia announces positive top-line results from phase 2 study of vadadustat in Japanese patients with non-dialysis-dependent chronic kidney disease...…

Ex-Akebia employee suspected of insider trading re-arrested

BOSTON (Reuters) - A former Akebia Therapeutics Inc employee accused of insider trading was re-arrested on Friday after violating…

Akebia (AKBA) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Stocks Under Scanner in the Biotech Space -- Acorda Therapeutics, Advaxis, Xbiotech, and Akebia Therapeutics

NEW YORK, September 11, 2017 /PRNewswire/ -- If you want a Stock Review on ACOR, ADXS, XBIT,…

Ex-Akebia employee faces losing bail in insider trading case

BOSTON, July 20 (Reuters) - A former Akebia Therapeutics Inc employee accused of insider trading faced the growing possibility of having his…